Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Viracta Therapeutics, Inc., a clinical-stage precision oncology company dedicated to treating and preventing virus-associated ...

Eleva, a pioneer in unlocking biologics based on a breakthrough manufacturing platform, and 3PBIOVIAN, a contract development ...

Pharmapack Europe has announced the winners of its newly reformatted Pharmapack Awards, recognizing excellence in six key ...

The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading ...

Independent research institute BioMed X has completed its oncology research project in partnership with Merck, the data from ...

PacBio, a developer of high-quality, accurate sequencing solutions, has appointed David Ruggiero as the company’s new Global ...

Recipharm’s new modular sterile filling system, specifically tailored for process development, pilot scale and clinical ...

Affinia Therapeutics, a gene therapy company with a pipeline of adeno-associated virus (AAV) gene therapies for devastating ...

Global oncology portfolio sales were $1.7 billion, up 12%. Imbruvica sales were $848 million, down 6%. Venclexta sales were $655 million, up 11%. Elahere revenues were $148 million.